Metalloproteinases: mediators of pathology and regeneration in the CNS. (Q36313201)

13 August 2017

1 reference

title

Metalloproteinases: mediators of pathology and regeneration in the CNS. (English)

1 reference

13 August 2017

0 references

V Wee Yong

1

1 reference

PubMed ID

16288297

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Nature Reviews Neuroscience

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

931-944

1 reference

13 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn1807

13 August 2017

0 references

cites work

How matrix metalloproteinases regulate cell behavior

1 reference

Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen

31 March 2020

1 reference

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

31 March 2020

1 reference

Regulation of matrix biology by matrix metalloproteinases

31 March 2020

1 reference

Matrix metalloproteinases: they're not just for matrix anymore!

31 March 2020

1 reference

Matrix metalloproteinases as modulators of inflammation and innate immunity

31 March 2020

1 reference

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

31 March 2020

1 reference

ADAMs: modulators of cell–cell and cell–matrix interactions

31 March 2020

1 reference

ADAMs: key components in EGFR signalling and development

31 March 2020

1 reference

Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail

31 March 2020

1 reference

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

31 March 2020

1 reference

The ADAMTS metalloproteinases

31 March 2020

1 reference

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

31 March 2020

1 reference

An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.

31 March 2020

1 reference

Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS

31 March 2020

1 reference

Metalloproteinases in biology and pathology of the nervous system.

31 March 2020

1 reference

Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases

31 March 2020

1 reference

Multiple roles for MMPs and TIMPs in cerebral ischemia

31 March 2020

1 reference

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

31 March 2020

1 reference

Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

31 March 2020

1 reference

Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

31 March 2020

1 reference

An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice

31 March 2020

1 reference

Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.

31 March 2020

1 reference

Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan

31 March 2020

1 reference

MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity

31 March 2020

1 reference

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

31 March 2020

1 reference

Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS.

31 March 2020

1 reference

MMP-9 microsatellite polymorphism and multiple sclerosis.

31 March 2020

1 reference

ADAM‐10 and ADAM‐17 in the inflamed human CNS

31 March 2020

1 reference

Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis

31 March 2020

1 reference

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

31 March 2020

1 reference

Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo

31 March 2020

1 reference

Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.

31 March 2020

1 reference

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

31 March 2020

1 reference

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

31 March 2020

1 reference

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

31 March 2020

1 reference

Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.

31 March 2020

1 reference

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

31 March 2020

1 reference

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

31 March 2020

1 reference

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.

31 March 2020

1 reference

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

31 March 2020

1 reference

Degradation of interleukin 1beta by matrix metalloproteinases.

31 March 2020

1 reference

ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activity

31 March 2020

1 reference

Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation

31 March 2020

1 reference

Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.

31 March 2020

1 reference

Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration

31 March 2020

1 reference

Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures

31 March 2020

1 reference

Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt.

31 March 2020

1 reference

Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.

31 March 2020

1 reference

Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves.

31 March 2020

1 reference

Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development

31 March 2020

1 reference

Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal

31 March 2020

1 reference

Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration.

31 March 2020

1 reference

MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum.

31 March 2020

1 reference

Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex

31 March 2020

1 reference

Integrin-growth factor interactions as regulators of oligodendroglial development and function

31 March 2020

1 reference

EGF family of growth factors: essential roles and functional redundancy in the nerve system

31 March 2020

1 reference

Inhibition of retinal growth cone activity by specific metalloproteinase inhibitors in vitro

31 March 2020

1 reference

NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells

31 March 2020

1 reference

The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae

31 March 2020

1 reference

Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum

31 March 2020

1 reference

Laminin-1 and the RKRLQVQLSIRT laminin-1 alpha1 globular domain peptide stimulate matrix metalloproteinase secretion by PC12 cells

31 March 2020

1 reference

The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila

31 March 2020

1 reference

Defining brain wiring patterns and mechanisms through gene trapping in mice.

31 March 2020

1 reference

Functional analysis of secreted and transmembrane proteins critical to mouse development.

31 March 2020

1 reference

ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.

31 March 2020

1 reference

Metalloproteases and guidance of retinal axons in the developing visual system.

31 March 2020

1 reference

Regulated cleavage of a contact-mediated axon repellent

31 March 2020

1 reference

Function of an axonal chemoattractant modulated by metalloprotease activity

31 March 2020

1 reference

The function of leak and kuzbanian during growth cone and cell migration.

31 March 2020

1 reference

UNC-71, a disintegrin and metalloprotease (ADAM) protein, regulates motor axon guidance and sex myoblast migration in C. elegans

31 March 2020

1 reference

Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points

31 March 2020

1 reference

Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro

31 March 2020

1 reference

Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration

31 March 2020

1 reference

Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons

31 March 2020

1 reference

Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue.

31 March 2020

1 reference

Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus

31 March 2020

1 reference

Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis.

31 March 2020

1 reference

Matrix Metalloproteinase Inhibition Alters Functional and Structural Correlates of Deafferentation-Induced Sprouting in the Dentate Gyrus

31 March 2020

1 reference

Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy

31 March 2020

1 reference

Chondroitinase ABC promotes functional recovery after spinal cord injury

31 March 2020

1 reference

Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse

31 March 2020

1 reference

Targeting the Nogo receptor to treat central nervous system injuries

31 March 2020

1 reference

Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR).

31 March 2020

1 reference

MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth

31 March 2020

1 reference

Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor

31 March 2020

1 reference

Ectodomain shedding of human Nogo-66 receptor homologue-1 by zinc metalloproteinases.

31 March 2020

1 reference

Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

31 March 2020

1 reference

Multiple roles of matrix metalloproteinases during apoptosis.

31 March 2020

1 reference

Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis

31 March 2020

1 reference

Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death

31 March 2020

1 reference

Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability

31 March 2020

1 reference

Regulation of cell survival by secreted proneurotrophins

31 March 2020

1 reference

Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases.

31 March 2020

1 reference

Why does remyelination fail in multiple sclerosis?

31 March 2020

1 reference

Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.

31 March 2020

1 reference

The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation.

31 March 2020

1 reference

Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice

31 March 2020

1 reference

ADAM (a disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes

31 March 2020

1 reference

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

31 March 2020

1 reference

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

31 March 2020

1 reference

Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage

31 March 2020

1 reference

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

31 March 2020

1 reference

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

31 March 2020

1 reference

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

31 March 2020

1 reference

The promise of minocycline in neurology.

31 March 2020

1 reference

Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors

31 March 2020

1 reference

Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia.

31 March 2020

1 reference

In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.

31 March 2020

1 reference

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

31 March 2020

1 reference

Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury

31 March 2020

1 reference

Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

31 March 2020

1 reference

Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice

31 March 2020

1 reference

Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN1807

1 reference

PubMed ID

16288297

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16288297